MedTrace Logo

Evaluation of Preferences of Consumers and Clinicians for the Management of Shave Biopsy Sites With a PolyMem Formulation Dressing or Current Standard of Care.

NCT00727870 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2012-03-02

No results posted yet for this study

Summary

Shave biopsies are often uncomfortable during the healing process. This is a preliminary study to determine if patients and clinicians prefer using PolyMem formulating dressings on shave biopsy sites compared to the current standard of practice, which is antibiotic ointment covered with a band-aid type dressing.

Conditions

  • Healing

Interventions

DEVICE

Shapes by PolyMem dressing

Shapes by PolyMem dressing on one site compared to antibiotic ointment covered with band-aid type dressing on second site

DEVICE

Shapes by PolyMem Silver Dressing

Shapes by PolyMem Silver dressing on one site compared to antibiotic ointment covered with band-aid type dressing on second site

DEVICE

Shapes by PolyMem on one site and Shapes by PolyMem Silver dressing on second site

Shapes by PolyMem dressing on one site. Shapes by PolyMem Silver dressing on other site.

Sponsors & Collaborators

  • Chicago Skin Clinic

    collaborator OTHER

  • University of Minnesota

    collaborator OTHER

  • Ferris Mfg. Corp.

    lead INDUSTRY

Principal Investigators

  • Andrew M Gorchynsky, MD · Chicago Skin Clinic

  • Danilo V Del Campo, MD · Chicago Skin Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2011-10-31
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00727870 on ClinicalTrials.gov